Trials / Sponsors / Shanghai Exuma Biotechnology Ltd.
Shanghai Exuma Biotechnology Ltd.
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma Diffuse Large B-cell-lymphoma, DLBCL, Nos Genetic Subtypes, Follicular Lymphoma Grade 3B | Phase 1 | 2025-03-19 |